FSC Wealth Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-125
Closed -$103K 172
2025
Q1
$103K Hold
125
0.07% 81
2024
Q4
$96.5K Hold
125
0.06% 86
2024
Q3
$111K Hold
125
0.08% 78
2024
Q2
$113K Buy
+125
New +$100K 0.08% 70

Other funds holding LLY

FSC Wealth Advisors's LLY Position: Q2 2025 in Review

FSC Wealth Advisors sold out of Eli Lilly (LLY) in Q2 2025, closing a stake of 125 shares — an estimated $103K sold.

FSC Wealth Advisors first reported a position in LLY in Q2 2024 and held it in 4 quarters. The position peaked at $113K in Q2 2024. 3,906 funds tracked by Wall St. Rank hold LLY as of Q2 2025.

  • FSC Wealth Advisors reported no remaining Eli Lilly position as of Q2 2025 after selling out during the quarter.
  • FSC Wealth Advisors sold 125 Eli Lilly shares in Q2 2025, an estimated $103K.
  • FSC Wealth Advisors first reported a position in Eli Lilly in Q2 2024 and held it in 4 quarters.
  • FSC Wealth Advisors's Eli Lilly position peaked at $113K in Q2 2024.
  • 3,906 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2025.

Based on FSC Wealth Advisors's 13F filing for Q2 2025, filed 11 Aug 2025.